简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:Mushroom's active ingredient is a drug called psilocybin, which has the potential to address conditions like anxiety and depression.
There's been a recent resurgence of interest in psychedelic drugs' potential to address conditions like anxiety and depression. Denver is set to become the first US city to decriminalize psychedelic mushrooms, after voters there approved a measure to direct police to make enforcing laws against them a low priority.Mushroom's active ingredient is a drug called psilocybin. Here's how it affects the body and brain.Visit Business Insider's homepage for more stories.In a slender and surprising victory for supporters of hallucinogenic or “magic” mushrooms, the psychedelic drug better known to scientists as psilocybin, Denver, Colorado yesterday voted to decriminalize the drugs.Once portrayed as illegal ways to “drop out” or “tune in,” psychedelic and semi-psychedelic drugs like psilocybin and ecstasy are beginning to turn into federally-regulated medicines. Part of the reason: scientific evidence is building that the substances may have the potential to help staunch symptoms of psychiatric diseases that are difficult to treat with existing therapies. Those diseases include severe depression, for example.Here's how psilocybin impacts the brain and body and produces its effects:
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.
"If the current rate of decline continues, claims will dip below 1M in the second or—more likely—third week of June," said economist Ian Shepherdson.
Before the coronavirus, luxury conglomerate LVMH was posting record-breaking revenues and sending Bernard Arnault's net worth soaring.
Intensive care specialist Chris Poynter said waiting for cases was like watching the tide go out before a tsunami. And then the tsunami never came.
New research from the anonymous social media network Blind shows job concerns among employees at tech companies jumped 33% in a month.